Kelly Chibale, Ph.D., the founder and director of the University of Cape Town's Drug Discovery and Development Center, will present a seminar on "Drug Discovery in Africa: Challenges, Status and Opportunities" at 4 p.m. Thursday, Dec. 8 in room 968 of Doisy Research Center.
|Kelly Chibale, Ph.D., directs the University of Cape Town's Drug Discovery and Development Center.|
The seminar is sponsored by the Department of Molecular Microbiology & Immunology and the Center for World Health and Medicine.
The Center for World Health and Medicine has been exploring opportunities to forge broader partnerships between SLU and the University of Cape Town. The universities are collaborating to establish an international clinical compound library and working together on proposals that could lead to the discovery of new therapeutic strategies for tuberculosis and malaria.
In April the University of Cape Town launched its Drug Discovery and Development Center, which is dedicated to identifying new chemicals that can be turned into lifesaving drugs for infectious diseases and medical conditions such as heart disease. Like SLU's Center for World Health and Medicine, the University of Cape Town's center aims to bridge the gap between basic science and clinical science to find new cures and treatments for deadly diseases.
Before Chibale founded the University of Cape Town's Drug Discovery and Development Center, he was director of the South African Medical Research Council Drug Discovery and Development Research Unit. He has been a chemistry professor at the University of Cape Town and member of the university's Institute of Infectious Disease and Molecular Medicine.
Chibale was a U.S. Fulbright senior research scholar, Wellcome Trust visiting fellow and Pfizer visiting professor. He was elected as a life fellow of the University of Cape Town and fellow of the Royal Society of South Africa. He received a 2010/2011 National and Science and Technology Forum-BHP Billiton Award for outstanding contributions to science, technology and innovation over the last five to 10 years.
Chibale has spoken extensively on the scientific, technological and economic challenges associated with finding drugs to treat tropical diseases. His research interest is developing drugs to treat diseases that are common in Africa such as malaria, tuberculosis, cancer helminthes and cardiovascular disease.